Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA): Pancreatic Neoplasms trials
The registry lists 16 Pancreatic Neoplasms studies with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 5Phase 3 2No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Spleen Preservation Versus Splenectomy in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)Not yet recruitingNCT07799298Not applicable
- Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)RecruitingNCT06939023Not applicable
- EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary ObstructionRecruitingNCT05595122Not applicable
- PREOPANC-4 Implementation Program for Locally Advanced Pancreatic CancerRecruitingNCT05524090
- Glucose Control Through a Bihormonal Artificial Pancreas in Patients After Total PancreatectomyActive, not recruitingNCT06346366Phase 3
- Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic PancreatitisCompletedNCT05906615Phase 2
- Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic CancerStatus unknownNCT04897854Phase 3
- Second Line Treatment With Nal-IRI and S1 in Pancreatic CancerStatus unknownNCT03986294Phase 2
- Pancreatic Locally Advanced Irresectable Cancer AblationStatus unknownNCT03690323Not applicable
- Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)CompletedNCT03513705Not applicable
- Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.Status unknownNCT03500068Not applicable
- Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerCompletedNCT02358161Phase 1/2
- Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility StudyCompletedNCT01995240Not applicable
- The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment OutcomeCompletedNCT01989000Not applicable
- Metformin Combined With Chemotherapy for Pancreatic CancerCompletedNCT01210911Phase 2
- Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01077986Phase 1/2